Resolute Capital Asset Partners LLC Acquires Shares of 10,000 Axon Enterprise, Inc. (NASDAQ:AXON)

Resolute Capital Asset Partners LLC purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,000 shares of the biotechnology company's stock, valued at approximately $2,942,000. Axon Enterprise comprises about 1.7% of Resolute Capital Asset Partners LLC's holdings, making the stock its 24th largest holding.

Several other large investors have also bought and sold shares of AXON. ICA Group Wealth Management LLC bought a new stake in shares of Axon Enterprise in the 4th quarter valued at about $26,000. Blue Trust Inc. raised its holdings in Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company's stock worth $27,000 after purchasing an additional 79 shares during the period. Trivant Custom Portfolio Group LLC bought a new position in shares of Axon Enterprise during the first quarter worth $31,000. First PREMIER Bank acquired a new position in shares of Axon Enterprise in the 1st quarter valued at $33,000. Finally, Rise Advisors LLC increased its position in shares of Axon Enterprise by 49.0% in the 1st quarter. Rise Advisors LLC now owns 143 shares of the biotechnology company's stock valued at $45,000 after buying an additional 47 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Axon Enterprise

In related news, CFO Brittany Bagley sold 4,338 shares of Axon Enterprise stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the transaction, the chief financial officer now owns 98,825 shares in the company, valued at $37,449,733.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the company's stock in a transaction on Monday, September 16th. The shares were sold at an average price of $380.99, for a total value of $380,990.00. Following the transaction, the director now directly owns 27,259 shares in the company, valued at $10,385,406.41. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Brittany Bagley sold 4,338 shares of Axon Enterprise stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the sale, the chief financial officer now directly owns 98,825 shares of the company's stock, valued at approximately $37,449,733.75. The disclosure for this sale can be found here. Insiders sold a total of 317,981 shares of company stock worth $115,662,734 over the last quarter. 6.10% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

AXON has been the topic of several recent analyst reports. Northland Securities lifted their target price on Axon Enterprise from $330.00 to $365.00 and gave the stock an "outperform" rating in a report on Thursday, August 8th. JMP Securities lifted their price objective on Axon Enterprise from $375.00 to $430.00 and gave the company an "outperform" rating in a report on Thursday, September 12th. Robert W. Baird increased their target price on Axon Enterprise from $360.00 to $400.00 and gave the stock an "outperform" rating in a research note on Tuesday, September 10th. Barclays lifted their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an "overweight" rating in a research note on Wednesday, August 7th. Finally, Needham & Company LLC reissued a "buy" rating and set a $400.00 price objective on shares of Axon Enterprise in a research report on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, Axon Enterprise has an average rating of "Moderate Buy" and a consensus price target of $365.38.

Axon Enterprise Stock Up 1.8 %

AXON traded up $6.73 on Thursday, hitting $389.74. 461,837 shares of the company were exchanged, compared to its average volume of 518,863. The stock's fifty day moving average is $344.06 and its 200-day moving average is $316.19. Axon Enterprise, Inc. has a 12 month low of $189.12 and a 12 month high of $391.55. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. The company has a market cap of $29.45 billion, a PE ratio of 113.96, a PEG ratio of 10.34 and a beta of 0.94.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.02 by $0.18. The company had revenue of $504.00 million for the quarter, compared to analysts' expectations of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business's revenue was up 34.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.80 EPS. Equities research analysts predict that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.